Top Authors

• Most frequent coverage on OPXA

• 
  Mike Havrilla (1964 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)
  • 32 Stem Cell Companies to Watch (Wed, Feb 4)

  More by Mike Havrilla on OPXA »
• 
  Stockerblog (455 followers)

  • Investing in Stem Cell Stocks: Growth Industry of the Future? (Wed, Feb 21)

  More by Stockerblog on OPXA »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Day In Review: Cell Genesys Climbs On GVAX Results (Wed, Apr 4)

  More by Centient Biotech Investor on OPXA »

• Most followed authors on OPXA

• 
  Mike Havrilla (1964 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)
  • 32 Stem Cell Companies to Watch (Wed, Feb 4)

  More by Mike Havrilla on OPXA »
• 
  Marco Hickey (1344 followers)

  • 24 Breakout Stocks on Big Volume (Sun, Aug 9)

  More by Marco Hickey on OPXA »
• 
  M. E. Garza (565 followers)

  • Adult Stem Cell Drugs and Therapies Are the Next Big Market (Thu, Jun 18)

  More by M. E. Garza on OPXA »

• Newest authors on OPXA

• 
  M. E. Garza (565 followers)

  • Adult Stem Cell Drugs and Therapies Are the Next Big Market (Thu, Jun 18)

  More by M. E. Garza on OPXA »
• 
  The Burrill Report (217 followers)

  • Biotech Discounts Galore (Sun, Aug 9)

  More by The Burrill Report on OPXA »
• 
  Marco Hickey (1344 followers)

  • 24 Breakout Stocks on Big Volume (Sun, Aug 9)

  More by Marco Hickey on OPXA »

• Most commented on OPXA

• 
  Mike Havrilla (1964 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)
  • 32 Stem Cell Companies to Watch (Wed, Feb 4)

  More by Mike Havrilla on OPXA »
• 
  Stockerblog (455 followers)

  • Investing in Stem Cell Stocks: Growth Industry of the Future? (Wed, Feb 21)

  More by Stockerblog on OPXA »
• 
  M. E. Garza (565 followers)

  • Adult Stem Cell Drugs and Therapies Are the Next Big Market (Thu, Jun 18)

  More by M. E. Garza on OPXA »